A New Earnings Season Commences

Moderna Inc. MRNA – Options Runners: 

We closed out the week on Friday morning by highlighting the nice moves made by the August contracts we’ve been tracking since June 21st,  the MRNA 08/20 $195-210 Calls. Additionally, we included some fresh weekly targets in the MRNA Weekly $265-$280 Calls.

Despite a rather poor day for the markets in general, Moderna continued to add impressively to its recent bullish surge. The stock has been in a general upward trend for the entire year, but that really kicked into overdrive over the past week.

Here are the new highs and total increases posted by our August calls, as well as the intraday ranges and total possible gains on the weeklies. Very impressive figures across the board: 

MRNA 08/20 $195-210 Calls
$195: 23.50-93.23 (+297%)
$200: 18.00-88.85 (+394%)
$210: 13.55-78.66 (+480%)
_____

MRNA Weekly $265-$280 Calls

$195: 9.30-24.00 (+158%)
$200: 6.05-19.05 (+214%)
$210: 3.50-13.97 (+299%)
$195: 1.27-9.95 (+683%)


Fresh Options Ideas: 

Just a reminder, another earnings season is going to heat up quickly with hundreds of companies slated to report this week, hundreds more next week, and so on. The remainder of July and much of August should yield a wealth of opportunities in that department.

This morning we’re going to be looking at a potential post-earnings play in Auto Nation and a chart play idea for Airbnb:

AN 08/20 $100-105 Calls
ABNB 09/17 $135-145 Calls 


Extended Watchlist:
CYTK, NRXP, OXBR, AEHR, HIRU, LTNC, WOGI, SBES, NSAV, TXTM, KATX, CHNC

Form-4 Alert & More

Options Update

Following up with our fresh options ideas from yesterday morning’s premarket report, we already saw some nice moves in the SPY Weekly $324-325 Calls and the AAPL 10/09 $105-106 Calls and, chances are, we are going to see some further increases today as well.

Here is what they’ve managed so far, and take note that we also want to add the AAPL 10/09 $110 Calls into the mix as well.

SPY Weekly $324-325 Calls
$324
: 3.17-5.96 (+88%)
$325: 2.71-5.26 (+94%)
_____

AAPL 10/09 $105-106 Calls 
$105: 4.25-8.07 (+90%)
$106: 4.00-7.45 (+86%)
_____

Fresh Options Ideas:
AZO Weekly $12.25 Calls


89Bio, Inc. ETNB

We are going to place ENTB on a bottom watch today after noticing a large Form-4 purchase toward the end of last week. A company director picked up an additional 1.3M shares at $28. Right now ENTB in trading in the $25-range.

This is an example of the kind of play we put on a longer term watch, despite most of our ideas being based on quick-strike opportunities.


Extended Watchlist:
ALYI, VNTH, GRST, HIRU, NPHC, JADA

Blue Horseshoe Stocks: HIRU, OWCP Recaps & More

Hiru Corp. HIRU

Yesterday we re-signaled HIRU, a stock we’ve mentioned a couple times in 2017 already, beginning with our very first report of the year, subsequent to which we would observe a low of .0011.

So far this week, the stock has really picked up the pace with two consecutive bullish sessions. Yesterday alone it traded in a range from .0021 to a new high of .0036 just prior to the close, putting in a 71% intraday move. From our observed low, it marks an overall upswing of 227%, not to mention the fact that it closed just a single tick below that high of day at .0035.

Such a performance definitely warrants continued observation on HIRU in sessions to come.


OWC Pharmaceutical Research Corp. OWCP

Speaking of late-day pushes, we got one out of OWCP yesterday, which ran from a morning low of .21 up to .2957. That is the highest we’ve seen it yet since our next most recent report on the stock which came in mid-November.  Following that, we would catch OWCP trading as low as .085. That means, at yesterday’s new top mark, we had witnessed an overall upswing of 248% in less than two months.

If we jump back slightly further to our report dated 09/29, you can see that we actually caught this one at the subpenny level (.0045) from which yesterday’s new high represented an earth-shattering 6471% (<–That is not a typo!)

Granted the fact that yesterday’s high was its highest recorded PPS since 2014, we’d have to designate this one as a blue sky breakout, and continue to stay on its trail. Like any rapid riser, awareness of a possible dip-and-rip at some point must be maintained as well.



Biocept, Inc. BIOC

We’re also going to want to keep tabs on BIOC after yesterday monumental move on the strength of an agreement the company struck with Blue Cross & Blue Shield of Texas (>>Read PR). It’s a potentially lucrative development, and that is really showing through with the resulting activity on the chart.

With the stock having shattered previous resistance yesterday, we’re going to be monitoring for a continuation of the terrific momentum buildup from yesterday, as well as the possibility for a subsequent dip-and-rip pattern that could provide us with healthy opportunities over the course of the next few days.


Extended Watchlist:
SDVI, CRTC, PMEA, OTTV, AEPP, LXRP